XBIO

Conviction 19HealthcareScan · Thu, Jun 25, 2026

XBIO$2.90+0.00%

ResistanceSupportVol 14

Vol MA14 21.27K

Mar 25Apr 13Apr 30May 18Jun 5Jun 24

Xenetic Biosciences, Inc.PHARMACEUTICAL PREPARATIONSwww.xeneticbio.com ↗

Price2.90

Change+0.00%

Gap-0.44%

Rel volume1.04×

Avg volume20.24K

Avg $ vol64.21K

SMA 203.10

SMA 503.11

SMA 2002.94

Price vs 50-6.71%

Price vs 200-1.50%

MA stackmixed

50/200 cross—

Supertrenddown · 3.36

RSI (14)43

MACD hist-0.03

MACD cross—

Stoch %K / %D20 / 22

ADX (14)18

+DI / −DI18 / 27

RSI divergence—

MACD divergence—

ATR %+5.83%

ADR %5.13%

52w high10.36

52w low2.02

From 52w high-72.01%

Above 52w low+43.56%

New 52w highNo

SqueezeOff

Bollinger width21.32%

%B0.19

Donchian pos20.13%

Donchian high3.50

Donchian low2.75

AVWAP (52w high)10.18

vs AVWAP high-71.52%

AVWAP (52w low)2.68

vs AVWAP low+8.04%

OBV trendUp

Chaikin MF (20)0.02

Today vs 20d1.04×

Avg vol (14d)21.27K

Avg vol (20d)20.24K

Avg $ vol (20d)64.21K

Market cap6.64M

RS 3m (vs SPY)-15.27%

RS 6m (vs SPY)+27.15%

RS line new highNo

Trend template2/8

Technical rank48.8

1 week-5.23%

1 month-4.26%

3 months-3.01%

6 months+34.88%

1 year+5.84%

YTD+34.88%

P/E-2.48

P/B0.96

P/S2.23

P/FCF-2.91

EPS-1.58

Div yield—

ROE-38.57%

ROA-33.90%

Debt/Eq0.08

Current7.93

EV/EBITDA0.04

Gross margin0.00%

Net margin-90.07%

Rev growth19.04%

EPS growth32.31%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-117.57K

Revenue806.92K

Net income-456.38K

Gross profit0

Free cash flow-2.29M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out—

Employees2

ListedWed, May 16, 2012

Free float1.96M

Float %85.5%

Short interest16.39K

Days to cover2.0d

Short volume10.8%

Squeeze score12 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction19 / 100

Pattern quality—

Tech rank48.8 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance3.42

Support2.84

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in XBIO

All disclosures →

No recent disclosed trades by Congress in XBIO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in XBIO · 1 buy

Insider	Side	Shares	Value	Traded	Filed
PARSLOW JAMES F Interim CEO and CFO · Common Stock · 2026-04-21	Grant	100K	$0	2026-04-21	2026-04-23

SEC filings

EDGAR filings in XBIO

EDGAR →

No recent SEC filings on file for XBIO.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.